MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2

Abstract Background We investigated the potential regulatory role of miR-219-5p in esophageal squamous cell carcinoma (ESCC) and looked at the underlying mechanisms in ESCC. Methods Real-time PCR was used to determine the levels of miR-219-5p in ESCC tissues and cell lines. The effects of miR-219-5p...

Full description

Bibliographic Details
Main Author: Qiang Ma
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Cellular & Molecular Biology Letters
Subjects:
Online Access:http://link.springer.com/article/10.1186/s11658-018-0129-6
_version_ 1830297227188240384
author Qiang Ma
author_facet Qiang Ma
author_sort Qiang Ma
collection DOAJ
description Abstract Background We investigated the potential regulatory role of miR-219-5p in esophageal squamous cell carcinoma (ESCC) and looked at the underlying mechanisms in ESCC. Methods Real-time PCR was used to determine the levels of miR-219-5p in ESCC tissues and cell lines. The effects of miR-219-5p and cyclin A2 (CCNA2) on cell proliferation and cell cycle progression were evaluated using MTT, colony formation and flow cytometry assays with ESCC cell lines EC9706 and TE-9. Bioinformatics techniques and the luciferase reporter assay were applied to validate CCNA2 as the miR-219-5p target in ESCC cells. The mRNA and protein levels of CCNA2 were measured using real-time PCR and western blotting. Results MiR-219-5p expression was significantly lower in ESCC tissues and cells than in healthy tissues. Upregulation of miR-219-5p repressed cell proliferation and induced cell cycle arrest at the G2/M phase. CCNA2 was identified and confirmed as a direct downstream target of miR-219-5p and its expression negatively correlated with miR-219-5p profiles in ESCC tissues. Knockdown of CCNA2 potentiated the effects of miR-219-5p on cell proliferation and cell cycle distribution. Conclusions Our results demonstrate that miR-219-5p might function as a tumor suppressor by directly targeting CCNA2 expression. It could serve as a new therapeutic target for ESCC.
first_indexed 2024-12-19T07:29:16Z
format Article
id doaj.art-d5429af927c74401a3ea6181eed03ef5
institution Directory Open Access Journal
issn 1425-8153
1689-1392
language English
last_indexed 2024-12-19T07:29:16Z
publishDate 2019-02-01
publisher BMC
record_format Article
series Cellular & Molecular Biology Letters
spelling doaj.art-d5429af927c74401a3ea6181eed03ef52022-12-21T20:30:45ZengBMCCellular & Molecular Biology Letters1425-81531689-13922019-02-0124111310.1186/s11658-018-0129-6MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2Qiang Ma0Department of Oncology, People’s Hospital of Xintai CityAbstract Background We investigated the potential regulatory role of miR-219-5p in esophageal squamous cell carcinoma (ESCC) and looked at the underlying mechanisms in ESCC. Methods Real-time PCR was used to determine the levels of miR-219-5p in ESCC tissues and cell lines. The effects of miR-219-5p and cyclin A2 (CCNA2) on cell proliferation and cell cycle progression were evaluated using MTT, colony formation and flow cytometry assays with ESCC cell lines EC9706 and TE-9. Bioinformatics techniques and the luciferase reporter assay were applied to validate CCNA2 as the miR-219-5p target in ESCC cells. The mRNA and protein levels of CCNA2 were measured using real-time PCR and western blotting. Results MiR-219-5p expression was significantly lower in ESCC tissues and cells than in healthy tissues. Upregulation of miR-219-5p repressed cell proliferation and induced cell cycle arrest at the G2/M phase. CCNA2 was identified and confirmed as a direct downstream target of miR-219-5p and its expression negatively correlated with miR-219-5p profiles in ESCC tissues. Knockdown of CCNA2 potentiated the effects of miR-219-5p on cell proliferation and cell cycle distribution. Conclusions Our results demonstrate that miR-219-5p might function as a tumor suppressor by directly targeting CCNA2 expression. It could serve as a new therapeutic target for ESCC.http://link.springer.com/article/10.1186/s11658-018-0129-6Esophageal squamous cell carcinomamiR-219-5pCCNA2Cell proliferationG2/M phase arrest
spellingShingle Qiang Ma
MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
Cellular & Molecular Biology Letters
Esophageal squamous cell carcinoma
miR-219-5p
CCNA2
Cell proliferation
G2/M phase arrest
title MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
title_full MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
title_fullStr MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
title_full_unstemmed MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
title_short MiR-219-5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting CCNA2
title_sort mir 219 5p suppresses cell proliferation and cell cycle progression in esophageal squamous cell carcinoma by targeting ccna2
topic Esophageal squamous cell carcinoma
miR-219-5p
CCNA2
Cell proliferation
G2/M phase arrest
url http://link.springer.com/article/10.1186/s11658-018-0129-6
work_keys_str_mv AT qiangma mir2195psuppressescellproliferationandcellcycleprogressioninesophagealsquamouscellcarcinomabytargetingccna2